健康・医療Vaccine Certificate for Quaranatine

(1) The certificate must be issued by a government or public institution

A vaccination certificate issued in Japan must be one of the following:
- Vaccination  Certificate of  COVID-19 issued by the Japanese government or a local government
- Certificate of  vaccination for COVID-19 issued by a local government
- Record of vaccination for COVID-19 issued by a medical institution
- Another certificate deemed equivalent to documents listed above

ページの先頭へ戻る

(2) The items must be indicated in Japanese or English

The following items must be indicated in Japanese or English: Name, date of birth, vaccine name/manufacturer, date of vaccination, number of doses administered.

※ If date of birth is not included in the certificate, it may still be considered valid if it contains your passport number or other information that can be used to verify that the vaccination certificate is yours.
※ If the vaccination certificate is in a language other than Japanese or English, it may be considered valid if it is accompanied by a Japanese or English translation and the content can be confirmed.

ページの先頭へ戻る

(3) First and Second Dose

The certificate must clearly indicate that you have received two doses from among the following vaccines (vaccine name/manufacturer):
・ Comirnaty/Pfizer
・ Vaxzevria/AstraZeneca
・ Spikevax/Moderna
・ JCOVDEN/Janssen
・ COVAXIN/Bharat Biotech
・ Nuvaxovid/Novavax

※ For the JCOVDEN/Janssen, one dose is considered equivalent to two doses. Hereafter the same.
※ Doses will also be considered valid even if both are not the same vaccine.
※ Regarding the application of measures based on Japan's Enhanced Border Measure (28), Comirnaty (manufactured by Fosun Pharma/BioNTech) , as well as Covishield and COVOVAX (manufactured by the Serum Institute of India), will be treated as identical to Comirnaty/Pfizer, Vaxzevria/AstraZeneca and Nuvaxovid/Novavax, respectively.

ページの先頭へ戻る

(4) Third Dose

The certificate must clearly indicate that you have received at a third dose, with it being one of the following vaccines (vaccine name/manufacturer):
・ Comirnaty/Pfizer
・ Spikevax/Moderna
・ Nuvaxovid/Novavax
・ Vaxzevria/AstraZeneca (effective from June 26th, 2022)
・ JCOVDEN/Janssen (effective from June 26th, 2022)

※ Regarding the application of measures based on Japan's Enhanced Border Measure (28), Comirnaty (manufactured by Fosun Pharma/BioNTech), as well as Covishield and COVOVAX (manufactured by the Serum Institute of India) will be treated as identical to Comirnaty/Pfizer, Vaxzevria/AstraZeneca and Nuvaxovid/Novavax, respectively.
※ Vaccines not listed in "(3) First and Second Dose" don’t count as the first or second dose.

ページの先頭へ戻る